BeiGene, Ltd.
NASDAQ Global SelectTotal Valuation
BeiGene, Ltd. carries a market capitalization of 20.21B, placing it among publicly traded companies globally. Its enterprise value stands at 21.96B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 20.21B |
| Enterprise Value | 21.96B |
Share Statistics
BeiGene, Ltd. currently has 1.38B shares outstanding.
| Shares Outstanding | 1.38B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 7.10, and the price-to-book ratio stands at -2.79.
| PE Ratio | N/A |
| PS Ratio | 7.10 |
| PB Ratio | -2.79 |
| P/TBV Ratio | 6.97 |
| P/FCF Ratio | 141.83 |
| P/OCF Ratio | -53.87 |
Enterprise Valuation
| EV / Sales | 6.62 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 132.20 |
Financial Position
BeiGene, Ltd. maintains a current ratio of 1.93, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.93 |
| Quick Ratio | 1.63 |
| Debt / Equity | 32.06 |
| Debt / EBITDA | -1.51 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -15.15 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.44 |
Taxes
| Income Tax | 62.04M |
| Effective Tax Rate | N/A |
Stock Price Statistics
BeiGene, Ltd.'s stock has gained approximately 19.137% over the past 52 weeks. The 50-day moving average sits at 191.05, while the 200-day moving average is 179.91.
| Beta (5Y) | N/A |
| 52-Week Price Change | 19.137% |
| 50-Day Moving Average | 191.05 |
| 200-Day Moving Average | 179.91 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, BeiGene, Ltd. generated 3.32B in revenue and converted that into -860.46M in net income, yielding earnings per share of -8.20. EBITDA reached -727.23M, while operating income came in at -872.57M.
| Revenue | 3.32B |
| Gross Profit | 2.78B |
| Operating Income | -872.57M |
| Pretax Income | -798.42M |
| Net Income | -860.46M |
| EBITDA | -727.23M |
| EBIT | -872.57M |
| Earnings Per Share (EPS) | -8.20 |
Balance Sheet
BeiGene, Ltd. holds 2.70B in cash and equivalents against 1.10B in total debt, resulting in a net debt position of -1.65B. Total book value stands at -8.45B, with working capital of 1.89B providing operational flexibility.
| Cash & Cash Equivalents | 2.70B |
| Total Debt | 1.10B |
| Net Debt | -1.65B |
| Equity (Book Value) | -8.45B |
| Book Value Per Share | -80.55 |
| Working Capital | 1.89B |
Cash Flow
BeiGene, Ltd. produced -437.43M in operating cash flow over the past twelve months. After subtracting -603.57M in capital expenditures, free cash flow totaled -1.04B - equivalent to -9.92 per share.
| Operating Cash Flow | -437.43M |
| Capital Expenditures | -603.57M |
| Free Cash Flow | -1.04B |
| FCF Per Share | -9.92 |
Margins
BeiGene, Ltd. operates with a gross margin of 83.74, reflecting its pricing power and cost economics. The operating margin of -26.31 and net profit margin of -25.94 provide insight into operational efficiency.
| Gross Margin | 83.74 |
| Operating Margin | -26.31 |
| Pretax Margin | -24.07 |
| Profit Margin | -25.94 |
| EBITDA Margin | -21.93 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -2.31 |
| FCF Yield | 0.71 |
Scores
BeiGene, Ltd. posts an Altman Z-Score of 4.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.32 |